Alpha-1

HomePatientsLung Disease Week at the ATS2017Alpha-1 ▶ Information for Experts
Information for Experts

Alpha-1 Week

ATS Educational Products on Alpha -1

2016

B11 NHLBI GRADS CONSORTIUM

2017

B2 THE LONG-TERM OXYGEN TREATMENT TRIAL (LOTT): IMPLICATIONS FOR COPD PATIENT CARE
B5 SMOKERS WITH PRESERVED SPIROMETRY: EARLY COPD?
B82 HOT TOPICS IN COPD: A PRO/CON DEBATE
C6 REDUCING READMISSIONS FOR COPD: STRATEGIES, ISSUES AND RESULTS
C88 COPD COMORBIDITIES: GREATER THAN THE SUM OF THE PARTS
D2 BRONCHOSCOPIC LUNG VOLUME REDUCTION: IS IT FINALLY A REALITY?
D10 ENVIRONMENTAL POLLUTION AND THE GLOBAL RISE IN COPD FOOTPRINT
D82 PUTTING THE 2017 GOLD COPD RECOMMENDATIONS INTO CLINICAL PRACTICE
PG8 PRACTICAL OUTCOME TOOLS IN COPD: FROM CLINICAL CARE TO CLINICAL TRIALS
PG12 BRONCH DAY: A COMPREHENSIVE, HANDS-ON GUIDE TO BASIC BRONCHOSCOPY AND EBUS

 

ClinicianATS Journal articles on Alpha -1

 

AJRCCM

Through the Looking Glass and What was Found There: Imaging Biomarkers of COPD
2017
Read Abstract

Update in Chronic Obstructive Pulmonary Disease 2016
2016
Read Abstract

Reaching for the Holy Grail of COPD Outcomes: Can Medications Modify Lung Function Decline?
2016
Read Abstract

Are All Steps Created Equal? Revisiting Pedometer Use During Pulmonary Rehabilitation for Individuals Living with COPD
2016
Read Abstract

Immune Activation in α1-Antitrypsin-Deficiency Emphysema. Beyond the Protease–Antiprotease Paradigm
Vol. 191, No. 4 (2015), pp. 402-409.
Read Abstract

Immune Modulation by α1-Antitrypsin. A Nice Concept, but Does It Influence Outcome?
Vol. 191, No. 4 (2015), pp. 363-364.
Read Abstract

miR-199a-5p Silencing Regulates the Unfolded Protein Response in Chronic Obstructive Pulmonary Disease and α1-Antitrypsin Deficiency
Vol. 189, No. 3 (2014), pp. 263-273.
Read Abstract

The Natural History of Lung Function after Lung Transplantation for α1-Antitrypsin Deficiency
Vol. 190, No. 3 (2014), pp. 274-281
Read Abstract

Z α1-Antitrypsin Confers a Proinflammatory Phenotype That Contributes to Chronic Obstructive Pulmonary Disease
Vol. 189, No. 8 (2014), pp. 909-931.
Read Abstract

Off-Target Rewards of Augmentation Therapy with α1-Antitrypsin
Vol. 190, No. 11 (2014), pp. 1203-1204.
Read Abstract

α1-Antitrypsin Activates Protein Phosphatase 2A to Counter Lung Inflammatory Responses
Vol. 190, No. 11 (2014), pp. 1229-1242.
Read Abstract

 

AJRCMB

Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity
2017
Read Abstract

Understanding the Relevance of the Mouse Cigarette Smoke Model of COPD Peering through the Smoke
2017
Read Abstract

Genetic Control of Fatty Acid β-Oxidation in Chronic Obstructive Pulmonary Disease
2017
Read Abstract

IL-23 Is Essential for the Development of Elastase-Induced Pulmonary Inflammation and Emphysema
2016
Read Abstract
Deficiency Mutations of Alpha-1 Antitrypsin. Effects on Folding, Function, and Polymerization
Vol. 54, No. 1 (2016), pp. 71-80.
Read Abstract

Alpha 1-antitrypsin Mitigates the Inhibition of Airway Epithelial Cell Repair by Neutrophil Elastase
(2015), pp. 4 - 56
Read Abstract

High-Density Lipoproteins Potentiate α1-Antitrypsin Therapy in Elastase-Induced Pulmonary Emphysema
Vol. 51, No. 4 (2014), pp. 536-549.
Read Abstract

α1-Antitrypsin Modulates Lung Endothelial Cell Inflammatory Responses to TNF-α
Vol. 49, No. 1 (2013), pp. 143-150.
Read Abstract

 

Annals

Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups
2017
Read Abstract

Hospital Procalcitonin Testing and Antibiotic Treatment of Patients Admitted for COPD Exacerbation
2017
Read Abstract

The Link between Reduced Inspiratory Capacity and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
2017
Read Abstract

Acetazolamide Use in Severe Chronic Obstructive Pulmonary Disease. Pros and Cons
2017
Read Abstract

Peak Inspiratory Flow Rate as a Criterion for Dry Powder Inhaler Use in Chronic Obstructive Pulmonary Disease
2017
Read Abstract

Characteristics of Alpha-1 Antitrypsin–Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease
Vol. 12, No. 12 (2015), pp. 1796-1804.
Read Abstract

Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol
Vol. 12, No. 10 (2015), pp. 1551-1560.
Read Abstract

Relationship of the 2011 Global Initiative for Chronic Obstructive Lung Disease Strategy to Clinically Relevant Outcomes in Individuals with α1-Antitrypsin Deficiency
Vol. 11, No. 6 (2014), pp. 859-864.
Read Abstract

 


 

ClinicianATS Statements, Guidelines and Reports

ATS Statements, Guidelines and Reports are printed in the American Journal of Respiratory and Critical Care Medicine. These documents are also available in PDF format. You may download one copy of any ATS document; there is no charge for this service. For examples, please Click Here.